Texas 2009 - 81st Regular

Texas House Bill HB2163 Compare Versions

The same version is selected twice. Please select two different versions to compare.

Version 1 (Old)

Version 2 (New)

Old	New	Differences
1	1	H.B. No. 2163
2	2
3	3
4	4	AN ACT
5	5	relating to a study regarding the provision of certain medications
6	6	through the Medicaid vendor drug program to children younger than
7	7	16 years of age.
8	8	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
9	9	SECTION 1. Subchapter B, Chapter 531, Government Code, is
10	10	amended by adding Section 531.0731 to read as follows:
11	11	Sec. 531.0731. STUDY REGARDING THE PROVISION OF CERTAIN
12	12	MEDICATION TO CHILDREN. (a) The commission shall conduct a study
13	13	to determine the appropriateness and safety of providing
14	14	antipsychotic or neuroleptic medication through the Medicaid
15	15	vendor drug program to children younger than 16 years of age.
16	16	(b) The study conducted under Subsection (a) must consider
17	17	the following factors relevant to the appropriateness and safety of
18	18	providing the medications to children:
19	19	(1) the physical and psychological medical diagnosis
20	20	of a child's condition;
21	21	(2) whether the United States Food and Drug
22	22	Administration has approved a medication for use by a child of a
23	23	certain age;
24	24	(3) whether a child has successfully taken a
25	25	medication previously;
26	26	(4) access to quality medical care for a child
27	27	receiving benefits under the program;
28	28	(5) the standard of care in the medical profession
29	29	regarding the provision of such medications to a child; and
30	30	(6) any other factor the commission considers
31	31	relevant.
32	32	(c) Not later than November 10, 2010, the executive
33	33	commissioner shall submit a report containing the results of the
34	34	study conducted under Subsection (a) to the governor, the
35	35	lieutenant governor, the speaker of the house of representatives,
36	36	and the chairs of the Senate Committee on Health and Human Services
37	37	and the House Committee on Public Health.
38	38	SECTION 2. This Act takes effect September 1, 2009.
39	39	______________________________ ______________________________
40	40	President of the Senate Speaker of the House
41	41	I certify that H.B. No. 2163 was passed by the House on May
42	42	15, 2009, by the following vote: Yeas 135, Nays 4, 1 present, not
43	43	voting; that the House refused to concur in Senate amendments to
44	44	H.B. No. 2163 on May 29, 2009, and requested the appointment of a
45	45	conference committee to consider the differences between the two
46	46	houses; and that the House adopted the conference committee report
47	47	on H.B. No. 2163 on May 31, 2009, by the following vote: Yeas 147,
48	48	Nays 0, 1 present, not voting.
49	49	______________________________
50	50	Chief Clerk of the House
51	51	I certify that H.B. No. 2163 was passed by the Senate, with
52	52	amendments, on May 25, 2009, by the following vote: Yeas 31, Nays
53	53	0; at the request of the House, the Senate appointed a conference
54	54	committee to consider the differences between the two houses; and
55	55	that the Senate adopted the conference committee report on H.B. No.
56	56	2163 on May 31, 2009, by the following vote: Yeas 31, Nays 0.
57	57	______________________________
58	58	Secretary of the Senate
59	59	APPROVED: __________________
60	60	Date
61	61	__________________
62	62	Governor